Comparative study between vaginal isosorbide mononitrate and misoprostol for induction of cervical ripening prior to first trimester surgical abortion

Authors

  • Pawan Yadav Indira IVF Hospital Private Limited, Lucknow, Uttar Pradesh, India
  • Tanya Singh Indira IVF Hospital Private Limited, Lucknow, Uttar Pradesh, India
  • Amrita Singh Indira IVF Hospital Private Limited, Lucknow, Uttar Pradesh, India
  • Savita Shukla Indira IVF Hospital Private Limited, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20250185

Keywords:

Cervical ripening, Missed abortion, Nitric oxide donor, Surgical evacuation, Misoprostol

Abstract

Background: To evaluate the efficacy of the tab. isosorbide mononitrate 80 mg and tab. misoprostol 400 µg given transvaginal for cervical ripening before surgical evacuation in early embryonic demise upto 12 weeks of gestation (missed abortion).

Methods: The present randomized controlled trial was conducted in Bebe Nanaki mother and child care centre, attached to govt. medical college, Amritsar, from August 2011 to September 2013 after approval of institutional research committee. All the 50 women were included after obtaining a written consent, and after proper history taking and examinations and were allocated randomly into two groups. In group A patients, tab. isosorbide mononitrate 80 mg was given and in group B patients, Tab. Misoprostol 400ug was given up to maximum of four doses until cervical dilatation of >8 mm has been achieved. Lack of cervical dilatation >8 mm after the 4th dose of medication was considered as a failure of treatment.

Results: In this study, the success rate was more with tab. misoprostol group (96%) as compared to tab. isosorbide mononitrate group (80%), whereas the failure rate with tab. misoprostol group was 4% and with tab. isosorbide mononitrate group was 20%. Cervical ripening with tab. misoprostol was rapid with less frequency of dosage and less induction to ripening interval. Specific side effects are there for both the groups.

Conclusions: In our study we observed that, tab. misoprostol appeared to be more effective than tab. isosorbide mononitrate.

Metrics

Metrics Loading ...

References

Kelly RW, Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev. 1994;15(5):684-706. DOI: https://doi.org/10.1210/er.15.5.684

Winkler M, Rath W. Changes in cervical extracellular matrix during pregnancy and parturition. J Perinat Med. 1999;27(1):45-60. DOI: https://doi.org/10.1515/JPM.1999.006

deWitt M. Cox is the rate limiting enzyme in the synthesis of PGs and exists in two isoforms, Cox-1 and Cox-2. Endocrinology. 1991;128:1825-32.

Maier JAM, Hla T, Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem. 1990;265:10805-08. DOI: https://doi.org/10.1016/S0021-9258(19)38515-1

Raz A, Wyche A, Siegel N. Needleman P. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem. 1988;263:3022-8. DOI: https://doi.org/10.1016/S0021-9258(18)69170-7

Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265:16737-40. DOI: https://doi.org/10.1016/S0021-9258(17)44821-6

Masferrer JL, Seibert K, Zweifel B. Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA. 1992;89:3917-21. DOI: https://doi.org/10.1073/pnas.89.9.3917

Stjernholm-Vladic Y, Månsson C, Masironi B, Åkerberg S, Wang H, Ekman-Ordeberg G, et al. Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol. 2004;2:74. DOI: https://doi.org/10.1186/1477-7827-2-74

Maul H, Longo M. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des. 2003;9(5):359-80. DOI: https://doi.org/10.2174/1381612033391784

Shafique U, Kazmi F, Rehana F. Vaginal isosorbide mononitrate and misoprostol for induction of cervical ripening prior to 1st trimester surgical evacuation of retained products of conception. JRMC. 2010;14(2):101-3.

Ledingham MA, Thomson AJ, Lunan CB, Greer IA, Norman JE. A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre-operative cervical ripening: a randomised controlled trial. Brit J Obstetr Gynaecol. 2001;108:276-80. DOI: https://doi.org/10.1111/j.1471-0528.2001.00041.x

Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE. Nitric oxide donors induce ripening of the human uterine cervix: a randomized controlled trial. Brit J Obstetr Gynaecol. 1997;104:1054-7. DOI: https://doi.org/10.1111/j.1471-0528.1997.tb12066.x

Thomson AJ, Lunan CB, Ledingham M, Howat RCL, Cameron IT, Greer IA, et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first trimester termination of pregnancy. The Lancet. 1998;352:1093-6. DOI: https://doi.org/10.1016/S0140-6736(98)01289-6

Duhan N. Gupta S, Dahiya K, Sirohiwal D, Rohilla S. Comparison of isosorbide mononitrate and misoprostol for cervical ripening in termination of pregnancy between 8 and 12 weeks: a randomized controlled trial. Arch Gynecol Obstetr. 2011;283:1245-8. DOI: https://doi.org/10.1007/s00404-010-1535-9

Radulovic N, Norstrom A, Ekerhovd E. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate. Acta Obstetr Gynecol. 2007;86:344-8. DOI: https://doi.org/10.1080/00016340601134598

El-Khayat W, Maged A, Omar H. A comparative study. between isosorbide mononitrate (IMN) versus misoprostol prior to hysteroscopy. Middle East Fertility Society J. 2010;15(4):278-80. DOI: https://doi.org/10.1016/j.mefs.2010.07.007

Downloads

Published

2025-01-29

How to Cite

Yadav, P., Singh, T., Singh, A., & Shukla, S. (2025). Comparative study between vaginal isosorbide mononitrate and misoprostol for induction of cervical ripening prior to first trimester surgical abortion. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(2), 512–517. https://doi.org/10.18203/2320-1770.ijrcog20250185

Issue

Section

Original Research Articles